Attached files
| file | filename |
|---|---|
| S-1 - REGISTRATION STATEMENT - CEL SCI CORP | cvm_s1.htm |
| EX-23.1 - CONSENT OF HART & HART, LLC - CEL SCI CORP | cvm_ex231.htm |
| EX-10.11 - SECURITIES PURCHASE AGREEMENT WITH ERGOMED - CEL SCI CORP | cvm_ex1011.htm |
| EX-10.10 - WARRANT SOLICITATION AGREEMENT WITH DAWSON JAMES SECURITIES, INC. - CEL SCI CORP | cvm_ex1010.htm |
| EX-5 - LEGAL OPINION - CEL SCI CORP | cvm_ex5.htm |
EXHIBIT 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING
FIRM
CEL-SCI Corporation
Vienna, Virginia
We hereby consent to the incorporation by reference in the
Prospectus constituting a part of this Registration Statement of
our reports dated December 16, 2019, except as to the amendment of
the financial statements and the material weakness, which are dated
December 23, 2019, relating to the financial statements and the
effectiveness of CEL-SCI Corporation’s internal control over
financial reporting, respectively, appearing in the Company’s
Annual Report on Form 10-K/A for the year ended September 30, 2019.
Our report on the financial statements contains an explanatory
paragraph regarding the Company’s ability to continue as a
going concern. Our report on the effectiveness of internal control
over financial reporting expresses an adverse opinion on the
effectiveness of the Company’s internal control over
financial reporting as of September 30, 2019.
/s/ BDO USA, LLP
Potomac, Maryland
July 2,
2020